These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8695355)

  • 1. Detection of circulating prostate-specific antigen-positive cells in patients with prostate cancer by flow cytometry and reverse transcription polymerase chain reaction.
    Fadlon EJ; Rees RC; McIntyre C; Sharrard RM; Lawry J; Hamdy FC
    Br J Cancer; 1996 Aug; 74(3):400-5. PubMed ID: 8695355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive prostate-specific antigen circulating cells detected by reverse transcriptase-polymerase chain reaction does not imply the presence of prostatic micrometastases.
    Thiounn N; Saporta F; Flam TA; Pages F; Zerbib M; Vieillefond A; Martin E; Debré B; Chevillard S
    Urology; 1997 Aug; 50(2):245-50. PubMed ID: 9255296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer.
    Gomella LG; Raj GV; Moreno JG
    J Urol; 1997 Aug; 158(2):326-37. PubMed ID: 9224297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-Time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) for the measurement of prostate-specific antigen mRNA in the peripheral blood of patients with prostate carcinoma using the taqman detection system.
    Gelmini S; Tricarico C; Vona G; Livi L; Melina AD; Serni S; Cellai E; Magrini S; Villari D; Carini M; Serio M; Forti G; Pazzagli M; Orlando C
    Clin Chem Lab Med; 2001 May; 39(5):385-91. PubMed ID: 11434386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of circulating tumor cells in men with localized prostate cancer.
    Seiden MV; Kantoff PW; Krithivas K; Propert K; Bryant M; Haltom E; Gaynes L; Kaplan I; Bubley G; DeWolf W
    J Clin Oncol; 1994 Dec; 12(12):2634-9. PubMed ID: 7527455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of circulating prostate cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) messages.
    Corey E; Arfman EW; Oswin MM; Melchior SW; Tindall DJ; Young CY; Ellis WJ; Vessella RL
    Urology; 1997 Aug; 50(2):184-8. PubMed ID: 9255285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients.
    Kurek R; Nunez G; Tselis N; Konrad L; Martin T; Roeddiger S; Aumüller G; Zamboglou N; Lin DW; Tunn UW; Renneberg H
    Clin Cancer Res; 2004 Sep; 10(17):5808-14. PubMed ID: 15355910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of prostate-specific antigen- or prostate-specific membrane antigen-positive circulating cells in prostatic cancer patients: clinical implications.
    Millon R; Jacqmin D; Muller D; Guillot J; Eber M; Abecassis J
    Eur Urol; 1999 Oct; 36(4):278-85. PubMed ID: 10473985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative real-time reverse transcription: polymerase chain reaction of prostate-specific antigen (PSA) for detection of circulating prostatic cells in patients with clinically localized prostate cancer.
    Llanes L; Ferruelo A; Luján M; Pascual C; García-Mediero JM; Berenguer A
    Prostate Cancer Prostatic Dis; 2005; 8(3):248-52. PubMed ID: 15897916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients.
    Sokoloff MH; Tso CL; Kaboo R; Nelson S; Ko J; Dorey F; Figlin RA; Pang S; deKernion J; Belldegrun A
    J Urol; 1996 Nov; 156(5):1560-6. PubMed ID: 8863538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of flow cytometry and RT-PCR in the detection of circulating PSA-positive cells in prostate cancer.
    Fadlon EJ; Hamdy FC
    Methods Mol Biol; 1998; 92():215-25. PubMed ID: 9664517
    [No Abstract]   [Full Text] [Related]  

  • 12. Enhanced detection of hematogenous circulating prostatic cells in patients with prostate adenocarcinoma by using nested reverse transcription polymerase chain reaction assay based on prostate-specific membrane antigen.
    Loric S; Dumas F; Eschwege P; Blanchet P; Benoit G; Jardin A; Lacour B
    Clin Chem; 1995 Dec; 41(12 Pt 1):1698-704. PubMed ID: 7497608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro detection of prostate cancer circulating cells by immunocytochemistry, flow cytometry and RT-PCR PSA].
    de la Taille A; Muscatelli B; Colombel M; Jouault H; Amsellem S; Mazeman E; Abbou CC; Chopin D
    Prog Urol; 1998 Dec; 8(6):1058-64. PubMed ID: 9894270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: a comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer.
    Pfitzenmaier J; Ellis WJ; Hawley S; Arfman EW; Klein JR; Lange PH; Vessella RL
    Urol Oncol; 2007; 25(3):214-20. PubMed ID: 17483018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of PSA-mRNA-bearing cells in the peripheral blood of patients after prostate biopsy.
    Hara N; Kasahara T; Kawasaki T; Bilim V; Tomita Y; Obara K; Takahashi K
    Br J Cancer; 2001 Aug; 85(4):557-62. PubMed ID: 11506496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of circulating tumor cells in patients with localized and metastatic prostatic carcinoma: clinical implications.
    Ghossein RA; Scher HI; Gerald WL; Kelly WK; Curley T; Amsterdam A; Zhang ZF; Rosai J
    J Clin Oncol; 1995 May; 13(5):1195-200. PubMed ID: 7537803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostate-specific membrane antigen and prostate-specific antigen-based assays.
    Israeli RS; Miller WH; Su SL; Powell CT; Fair WR; Samadi DS; Huryk RF; DeBlasio A; Edwards ET; Wise GJ
    Cancer Res; 1994 Dec; 54(24):6306-10. PubMed ID: 7527294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Numeric definition of the clinical performance of the nested reverse transcription-PCR for detection of hematogenous epithelial cells and correction for specific mRNA of non-target cell origin as evaluated for prostate cancer cells.
    Schamhart D; Swinnen J; Kurth KH; Westerhof A; Kusters R; Borchers H; Sternberg C
    Clin Chem; 2003 Sep; 49(9):1458-66. PubMed ID: 12928226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of circulating tumor cells in patients with prostate cancer using prostate specific membrane-derived primers in the polymerase chain reaction.
    Noguchi M; Miyajima J; Itoh K; Noda S
    Int J Urol; 1997 Jul; 4(4):374-9. PubMed ID: 9256327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early postoperative peripheral blood reverse transcription PCR assay for prostate-specific antigen is associated with prostate cancer progression in patients undergoing radical prostatectomy.
    Shariat SF; Kattan MW; Song W; Bernard D; Gottenger E; Wheeler TM; Slawin KM
    Cancer Res; 2003 Sep; 63(18):5874-8. PubMed ID: 14522912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.